232 related articles for article (PubMed ID: 22527994)
1. Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms.
Campos D; Monaga M
Metab Brain Dis; 2012 Jun; 27(2):121-9. PubMed ID: 22527994
[TBL] [Abstract][Full Text] [Related]
2. Evidence of lysosomal membrane permeabilization in mucopolysaccharidosis type I: rupture of calcium and proton homeostasis.
Pereira VG; Gazarini ML; Rodrigues LC; da Silva FH; Han SW; Martins AM; Tersariol IL; D'Almeida V
J Cell Physiol; 2010 May; 223(2):335-42. PubMed ID: 20082302
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients.
Bhalla A; Ravi R; Fang M; Arguello A; Davis SS; Chiu CL; Blumenfeld JR; Nguyen HN; Earr TK; Wang J; Astarita G; Zhu Y; Fiore D; Scearce-Levie K; Diaz D; Cahan H; Troyer MD; Harris JM; Escolar ML
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707880
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
5. Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.
Hampe CS; Eisengart JB; Lund TC; Orchard PJ; Swietlicka M; Wesley J; McIvor RS
Cells; 2020 Aug; 9(8):. PubMed ID: 32764324
[TBL] [Abstract][Full Text] [Related]
6. Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice.
Baldo G; Lorenzini DM; Santos DS; Mayer FQ; Vitry S; Bigou S; Heard JM; Matte U; Giugliani R
Mol Genet Metab; 2015 Feb; 114(2):138-45. PubMed ID: 25541102
[TBL] [Abstract][Full Text] [Related]
7. Impaired Hematopoiesis and Disrupted Monocyte/Macrophage Homeostasis in Mucopolysaccharidosis Type I Mice.
Viana GM; Buri MV; Paredes-Gamero EJ; Martins AM; D'Almeida V
J Cell Physiol; 2016 Mar; 231(3):698-707. PubMed ID: 26235607
[TBL] [Abstract][Full Text] [Related]
8. Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Aguiar O; Viana GM; D'Almeida V
Mol Biol Rep; 2021 Jan; 48(1):363-370. PubMed ID: 33319323
[TBL] [Abstract][Full Text] [Related]
9. Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI.
Tessitore A; Pirozzi M; Auricchio A
Pathogenetics; 2009 Jun; 2(1):4. PubMed ID: 19531206
[TBL] [Abstract][Full Text] [Related]
10. Restoration of lysosomal function after damage is accompanied by recycling of lysosomal membrane proteins.
Eriksson I; Wäster P; Öllinger K
Cell Death Dis; 2020 May; 11(5):370. PubMed ID: 32409651
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B.
Ryazantsev S; Yu WH; Zhao HZ; Neufeld EF; Ohmi K
Mol Genet Metab; 2007 Apr; 90(4):393-401. PubMed ID: 17185018
[TBL] [Abstract][Full Text] [Related]
12. Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I.
Swaroop M; Brooks MJ; Gieser L; Swaroop A; Zheng W
Hum Mol Genet; 2018 Oct; 27(20):3612-3626. PubMed ID: 30052969
[TBL] [Abstract][Full Text] [Related]
13. Differences in MPS I and MPS II Disease Manifestations.
Hampe CS; Yund BD; Orchard PJ; Lund TC; Wesley J; McIvor RS
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360653
[TBL] [Abstract][Full Text] [Related]
14. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.
Martins C; Hůlková H; Dridi L; Dormoy-Raclet V; Grigoryeva L; Choi Y; Langford-Smith A; Wilkinson FL; Ohmi K; DiCristo G; Hamel E; Ausseil J; Cheillan D; Moreau A; Svobodová E; Hájková Z; Tesařová M; Hansíková H; Bigger BW; Hrebícek M; Pshezhetsky AV
Brain; 2015 Feb; 138(Pt 2):336-55. PubMed ID: 25567323
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex.
Viana GM; Gonzalez EA; Alvarez MMP; Cavalheiro RP; do Nascimento CC; Baldo G; D'Almeida V; de Lima MA; Pshezhetsky AV; Nader HB
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093427
[TBL] [Abstract][Full Text] [Related]
17. Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.
Marcó S; Pujol A; Roca C; Motas S; Ribera A; Garcia M; Molas M; Villacampa P; Melia CS; Sánchez V; Sánchez X; Bertolin J; Ruberte J; Haurigot V; Bosch F
Dis Model Mech; 2016 Sep; 9(9):999-1013. PubMed ID: 27491071
[TBL] [Abstract][Full Text] [Related]
18. Phenotype prediction for mucopolysaccharidosis type I by in silico analysis.
Ou L; Przybilla MJ; Whitley CB
Orphanet J Rare Dis; 2017 Jul; 12(1):125. PubMed ID: 28676128
[TBL] [Abstract][Full Text] [Related]
19. Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics.
Jones MZ; Alroy J; Boyer PJ; Cavanagh KT; Johnson K; Gage D; Vorro J; Render JA; Common RS; Leedle RA; Lowrie C; Sharp P; Liour SS; Levene B; Hoard H; Lucas R; Hopwood JJ
J Neuropathol Exp Neurol; 1998 Feb; 57(2):148-57. PubMed ID: 9600207
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of lysosomal storage disorders: beyond the engorgement of lysosomes to abnormal development and neuroinflammation.
Fiorenza MT; Moro E; Erickson RP
Hum Mol Genet; 2018 Aug; 27(R2):R119-R129. PubMed ID: 29718288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
